SCHEMBL26837273

SCHEMBL26837273

Fc1cc2[nH]c3c(c2cc1Cl)CCN1CCCC3C1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AR P10275 2/20 0.34
▸ KIF11 P52732 1/20 0.33
▸ TXN P10599 1/20 0.33
▸ ABCB1 P08183 1/20 0.32
▸ ABCG2 Q9UNQ0 1/20 0.32
▸ MAPT P10636 2/20 0.32
▸ ALOX15 P16050 2/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ GLA P06280 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ BRD3 Q15059 2/20 0.32
▸ HTR2A P28223 3/20 0.32
▸ HTR2C P28335 3/20 0.32
▸ ADRA1D P25100 1/20 0.32
▸ ADRA1A P35348 1/20 0.32
▸ ADRA1B P35368 1/20 0.32
▸ MAPK1 P28482 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26837276 0.95 AR (0.39) ARKIF11ABCB1ABCG2MAPT
SCHEMBL26837304 0.90 ADRA1D (0.34) KIF11ABCB1ABCG2MEN1KMT2A
SCHEMBL26837280 0.90 AR (0.35) ARKIF11ABCG2MAPTALOX15
SCHEMBL26837294 0.86 BRD3 (0.35) KIF11BRD3ADRA1DADRA1AADRA1B
SCHEMBL26837266 0.86 MAPT (0.34) MAPTALOX15SMN1; SMN2MEN1GLA
SCHEMBL26837291 0.83 BRD3 (0.35) BRD3ADRA1DADRA1AADRA1BCHRNA7
SCHEMBL26837269 0.83 MAPT (0.34) MAPTALOX15SMN1; SMN2MEN1GLA
SCHEMBL26839908 0.83 NCOA1 (0.46) ABCB1ABCG2MAPTBRD3HTR2A
SCHEMBL26839915 0.83 MAPT (0.38) ABCB1ABCG2MAPTHTR2AHTR2C
SCHEMBL26837307 0.81 HTR2A (0.41) ABCB1ABCG2BRD3HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382919-A1 OXA- IBOGAINE INSPIRED ANALOGUES FOR TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2023-11-30 — — US disclosed
US-20230382919-A1 OXA- IBOGAINE INSPIRED ANALOGUES FOR TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382919-A1 OXA- IBOGAINE INSPIRED ANALOGUES FOR TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS GRIA4, GRIA3, GRIN3A AR 273/4885KIF11 3986/4885TXN 2149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback